UK’s Vaccine Taskforce Appoints Deputy Head

Dr Clive Dix, chairman of biotechnology company Touchlight focused on the discovery and development of DNA-based genetic medicines, has been appointed Deputy Chair of the UK’s Vaccine Taskforce. In this role, Clive will be responsible for building the UK’s vaccine response to Covid-19.

Jonny Ohlson, Touchlight’s founder and CEO, commented: “With over 30 years of experience in life science research, including more than 20 in senior pharma positions, Clive has worked at the forefront of vaccine discovery and development. He has been Chairman of Touchlight for 10 years, providing invaluable guidance into the development of our platform and pipeline, which includes both prophylactic and therapeutic vaccines.

“Clive is a visionary with extraordinary insights into vaccine development. We are convinced that he is the right person to take forward the Covid-19 vaccine initiative in the UK.”